Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India. The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag formulations, inhalers, and sprays and IV infusion. It also provides dry syrups, lyophilized vials, prefilled syringes, emulsion injection, and topicals. Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India.

Revenue projections:

Revenue projections for CAPLIPOINT
Revenue projections for CAPLIPOINT

CAPLIPOINT's revenue projections show a decrease from last year, which tends to make investors more cautious. This could have a negative impact on the company's bottom line, as lower revenues typically suggest reduced profitability and growth potential, prompting concern among investors.

Financial Ratios:

currentRatio 6.965000
forwardPE 19.276724
debtToEquity 0.174000
earningsGrowth 0.175000
revenueGrowth 0.104000
grossMargins 0.602140
operatingMargins 0.300570
trailingEps 70.260000
forwardEps 0.000000

Caplin Point Laboratories Limited's current ratio is 6.965, signaling that the company has sufficient cash reserves and current assets to cover its short-term debt obligations. This suggests financial stability, as Caplin Point Laboratories Limited should not face any issues meeting its short-term liabilities with available resources.
CAPLIPOINT's Forward PE being in a good range indicates the stock is priced well relative to its earnings. It is not overvalued, leaving space for future growth, making it an appealing option for investors interested in long-term value appreciation.
Caplin Point Laboratories Limited's positive earnings and revenue growth suggest the company is on a path to business expansion. This upward trend signals strong financial health, indicating that Caplin Point Laboratories Limited is well-positioned for sustained growth in both profits and revenue.
CAPLIPOINT's positive gross and operating margins highlight its profitability and operational efficiency. These strong margins demonstrate the company's ability to control costs while generating substantial revenue, contributing to a healthy financial performance.

Price projections:

Price projections for CAPLIPOINT
Price projections for CAPLIPOINT



Recommendation changes over time:

Recommendations trend for CAPLIPOINT
Recommendations trend for CAPLIPOINT


The recent buy bias from analysts suggests Caplin Point Laboratories Limited is seen as a strong investment, encouraging more investors to consider it. With this favorable sentiment, Caplin Point Laboratories Limited appears to be a reliable option for parking money, offering stability and long-term growth potential in the stock market.